Insider Selling: Heino Lennartz Sells 7,555 Shares of West Pharmaceutical Services Stock (WST)
West Pharmaceutical Services (NYSE:WST) Insider Heino Lennartz sold 7,555 shares of West Pharmaceutical Services stock on the open market in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $39.65, for a total transaction of $299,555.75. Following the sale, the insider now directly owns 20,974 shares of the company’s stock, valued at approximately $831,619. The sale was disclosed in a document filed with the SEC, which is available at this link.
West Pharmaceutical Services (NYSE:WST) traded up 1.25% on Thursday, hitting $41.005. The stock had a trading volume of 115,062 shares. West Pharmaceutical Services has a one year low of $36.77 and a one year high of $51.12. The stock’s 50-day moving average is $41.12 and its 200-day moving average is $43.50. The company has a market cap of $2.902 billion and a price-to-earnings ratio of 25.60.
West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, July 31st. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.05. The company had revenue of $368.90 million for the quarter, compared to the consensus estimate of $368.60 million. During the same quarter in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. Analysts expect that West Pharmaceutical Services will post $1.84 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, November 5th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 1.09%.
Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of West Pharmaceutical Services in a research note on Tuesday, August 5th. They now have a $45.00 price target on the stock, down previously from $47.00.
West Pharmaceutical Services, Inc (NYSE:WST) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.